Zocef CV – Bottle of 30 ml Dry Syrup (125 mg / 31.5 mg)

Description

Zocef CV – Bottle of 30 ml Dry Syrup (125 mg / 31.5 mg)

Product Name: Zocef CV
Formulation: Dry Syrup (for reconstitution)
Pack Size: 30 ml Bottle
Dosage Strength: 125 mg of Cefuroxime + 31.5 mg of Clavulanic Acid per 5 ml (after reconstitution)

Composition:

• Cefuroxime (125 mg) per 5 ml (after reconstitution)
• Clavulanic Acid (31.5 mg) per 5 ml (after reconstitution)

Explanation of Active Ingredients:

• Cefuroxime (125 mg): Cefuroxime is a second-generation cephalosporin antibiotic. It works by inhibiting the bacterial cell wall synthesis, causing bacteria to break down and ultimately die. Cefuroxime is effective against a wide range of bacterial pathogens, both Gram-positive and Gram-negative.
• Clavulanic Acid (31.5 mg): Clavulanic acid is a beta-lactamase inhibitor. It works by preventing bacteria from producing beta-lactamase, an enzyme that can degrade antibiotics like cefuroxime. This enhances the effectiveness of cefuroxime, particularly against beta-lactamase-producing bacteria.

Indications:

Zocef CV 125/31.5 mg syrup is used to treat a variety of bacterial infections, especially those caused by beta-lactamase-producing organisms. It is commonly prescribed for the following types of infections:

• Respiratory Tract Infections: Pneumonia, bronchitis, sinusitis, tonsillitis, and pharyngitis.
• Urinary Tract Infections: Such as cystitis, pyelonephritis, and other related infections.
• Skin and Soft Tissue Infections: Including abscesses, cellulitis, and infected wounds.
• Ear Infections: Otitis media.
• Bone and Joint Infections: Osteomyelitis.
• Gastrointestinal Infections: Certain bacterial gastroenteritis.

Dosage:

The dosage for Zocef CV 125/31.5 mg Syrup should be determined by a healthcare provider, based on the patient’s age, weight, the type of infection, and its severity.

• Typical Pediatric Dose: After reconstitution, 5 ml of syrup (containing 125 mg of Cefuroxime and 31.5 mg of Clavulanic Acid) is generally administered twice daily or as prescribed by the doctor.
• Dosage for Adults: The usual adult dose is 5 ml twice daily, but this may vary depending on the condition being treated.

The syrup should be shaken well before each use to ensure an even distribution of the medication. It is generally taken with or without food, but following the doctor’s instructions is important.

Note: Complete the full course of the antibiotic even if symptoms improve to prevent the infection from recurring and to minimize the risk of antibiotic resistance.

Reconstitution Instructions:

• Before use, the dry syrup needs to be reconstituted by adding a specific amount of water (usually 20-25 ml) to the bottle.
• Shake the bottle well after adding the water to dissolve the powder completely. Once mixed, the syrup is ready for use.

Storage Instructions:

• Before reconstitution: Store at room temperature (10°C to 30°C) in a cool, dry place, away from sunlight and moisture.
• After reconstitution: Store the syrup in the refrigerator (2°C to 8°C). It should be used within 7 days after reconstitution.
• Keep the syrup tightly closed and out of the reach of children.

Manufacturer & Labeler:

• Zocef CV is manufactured by FDC Ltd., a leading pharmaceutical company.

Schedule H Drug Warning:

• To be sold by retail on the prescription of a Registered Medical Practitioner only.
  • Zocef CV Syrup is a Schedule H drug, meaning it can only be dispensed with a valid prescription from a healthcare provider. This ensures that it is used correctly and safely under medical supervision.